| Resistance diagnostics as a public health tool to combat antibiotic resistance: A model-based evaluation D McAdams, K Wollein Waldetoft, C Tedijanto, M Lipsitch, SP Brown PLoS biology 17 (5), e3000250, 2019 | 40 | 2019 |
| To harm or not to harm? On the evolution and expression of virulence in group A streptococci KW Waldetoft, L Råberg Trends in microbiology 22 (1), 7-13, 2014 | 32 | 2014 |
| Localization-triggered bacterial pathogenesis R Lood, KW Waldetoft, P Nordenfelt Future microbiology 10 (10), 1659-1668, 2015 | 22 | 2015 |
| Saliva-induced clotting captures streptococci: novel roles for coagulation and fibrinolysis in host defense and immune evasion K Wollein Waldetoft, T Mohanty, C Karlsson, M Mörgelin, IM Frick, ... Infection and Immunity 84 (10), 2813-2823, 2016 | 16 | 2016 |
| Streptococcal surface proteins activate the contact system and control its antibacterial activity KW Waldetoft, L Svensson, M Mörgelin, AI Olin, DP Nitsche-Schmitz, ... Journal of Biological Chemistry 287 (30), 25010-25018, 2012 | 15 | 2012 |
| Alternative therapeutics for self-limiting infections—An indirect approach to the antibiotic resistance challenge K Wollein Waldetoft, SP Brown PLoS biology 15 (12), e2003533, 2017 | 12 | 2017 |
| Evolving antibiotics against resistance: A potential platform for natural product development? K Wollein Waldetoft, J Gurney, J Lachance, PA Hoskisson, SP Brown MBio 10 (6), 10.1128/mbio. 02946-19, 2019 | 9 | 2019 |
| Proliferation and benevolence—A framework for dissecting the mechanisms of microbial virulence and health promotion K Wollein Waldetoft, L Råberg, R Lood Evolutionary Applications 13 (5), 879-888, 2020 | 6 | 2020 |
| Defining the benefits of antibiotic resistance in commensals and the scope for resistance optimization K Wollein Waldetoft, S Sundius, R Kuske, SP Brown MBio 14 (1), e01349-22, 2023 | 5 | 2023 |
| Hygiene may attenuate selection for antibiotic resistance by changing microbial community structure M Aspenberg, S Maad Sasane, F Nilsson, SP Brown, K Wollein Waldetoft Evolution, Medicine, and Public Health 11 (1), 1-7, 2023 | 4* | 2023 |
| Challenges and opportunities for cheat therapy in the control of bacterial infections J Gurney, C Simonet, KW Waldetoft, SP Brown Natural Product Reports 39 (2), 325-334, 2022 | 3 | 2022 |
| Surface proteins of group G Streptococcus in different phases of growth: patterns of production and implications for the host–bacteria relationship K Wollein Waldetoft, C Karlsson, M Gram, J Malmström, M Mörgelin, ... Microbiology 160 (2), 279-286, 2014 | 2 | 2014 |
| Evolving antibiotic spectrum K Wollein Waldetoft, SP Brown Proceedings of the National Academy of Sciences 119 (41), e2214267119, 2022 | 1 | 2022 |
| Variation in pneumococcal invasiveness metrics is driven by serotype carriage duration and initial risk of disease BJ Metcalf, KW Waldetoft, BW Beall, SP Brown Epidemics 45, 100731, 2023 | | 2023 |
| Mapping infectious disease mortality onto the within-host dynamics of pathogen growth T O’Sullivan, KW Waldetoft, SP Brown medRxiv, 2020.06. 20.20134205, 2020 | | 2020 |
| Controlling Rogue Cells in Cancer and Bacterial Infections KW Waldetoft, JF McDonald, SP Brown Ecology and Evolution of Cancer, 243-246, 2017 | | 2017 |
| Streptococcal virulence and the coagulation system. K Wollein Waldetoft Lund University Faculty of Medicine Doctoral Dissertation Series 2013 (120), 2013 | | 2013 |
